Dr. V S N Rao, Chief Radiation Oncologist, Director - Medical Services & HOD - Radiation Oncology,HCG Cancer Centre, Vijayawada Pancreatic cancer is a devastating disease that affects thousands of people worldwide each year. In India, pancreatic cancer is becoming a significant public health concern, particularly
Participants using tirzepatide lost 22.8 kg and participants on semaglutide lost 15.0 kg SURMOUNT-5 compared tirzepatide, a dual GIP and GLP-1 receptor agonist, to semaglutide, a mono GLP-1 receptor agonist in adults living with obesity without diabetes Eli Lilly and Company (NYSE: LLY) today announced topline results
The patient presented with abdominal distension, weight loss, and loss of appetite over two months and underwent Hypothermic, Intraperitoneal, Exothermic Chemotherapy (HIPEC) suregry~ A team led by Dr Donald Babu,Consultant Surgical Oncologist, Medicover Hospital, Navi Mumbai saved the life of a 60-year-old woman detected with pseudomyxoma peritonei (PMP)
Chintamani - Chairman and Head Department of Surgical Oncology Sir Ganga Ram Hospital New Delhi Pancreatic cancer is a life-threatening malignancy that originates in the tissues of the pancreas, a hidden though crucial organ located behind the stomach. Pancreas plays an essential role in digestion and
Dr. Raghavendra Ramanjulu, Lead Consultant - Palliative Medicine & Rehabilitation, Aster CMI Hospital, Bangalore Pancreatic cancer, often dubbed the “silent killer,” is one of the deadliest forms of cancer due to its asymptomatic onset and rapid progression. Globally, it remains a significant cause of cancer-related deaths,
